JUPITER Primary Trial End Point: MI, Stroke, UA/Revascularization, CV Death A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently…

JUPITER AHA November 9, 2008 A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels…

A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive Protein (hsCRP):…

The main methods of investigation of cardiovascular system. Fibrinogen and Atherosclerosis Promotes atherosclerosis Essential component of platelet aggregation Relates to…

A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive Protein (hsCRP):…

A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive Protein (hsCRP):…

A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated Levels of C-Reactive Protein (hsCRP):…

Presenter Disclosure Information Disclosure Information: Paul M Ridker, MD, FACC Dr Ridker is listed as a co-inventor on patents held by the Brigham and Womenâs Hospital…

Presenter Disclosure Information Paul M Ridker, MD, FACC Dr Ridker is listed as a co-inventor on patents held by the Brigham and Womenâs Hospital that relate to the use…